PTMA Human Pre-designed siRNA Set A contains three designed siRNAs for PTMA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTMS Human Pre-designed siRNA Set A contains three designed siRNAs for PTMS gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTN Human Pre-designed siRNA Set A contains three designed siRNAs for PTN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTOV1 Human Pre-designed siRNA Set A contains three designed siRNAs for PTOV1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTP1B-IN-24 (Compound 9) is a reversible PTP1B inhibitor with an IC50 value of 1.4 μM, and PTP1B-IN-24 can enhance the thermal stability of PTP1B. PTP1B-IN-24 can restore PA- (HY-N0830) induced insulin resistance by increasing the phosphorylation levels of IRS1 and AKT[1].

PTP1B-IN-25 (Compound 19) is a PTP1B inhibitor with remarkable antiviral, antibacterial, and antidiabetic activities. PTP1B-IN-25 has IC50 values of 0.37 μM, 8.6 μM, 3.7 μM, and 29 μM against PTP1B, HIV, α-Glucosidase, and methicillin-resistant Staphylococcus aureus (MRSA) respectively[1].

PTP1B-IN-26 (Compound 7a) is a derivative of phenylthiosemicarbazide‐phenoxy‐1,2,3‐triazole‐N‐phenylacetamide. PTP1B-IN-26 is an inhibitor of protein tyrosine phosphatase 1B (PTP-1B). PTP1B-IN-26 is a competitive inhibitor. PTP1B-IN-26 can be used to research in type 2 diabetes.

PTP1B-IN-27 (Compound 7i) is an inhibitor of protein tyrosine phosphatase 1-B (PTP‐1B)(IC50=8.2 µM). PTP1B-IN-27 also inhibits α-Glucosidase (IC50=120 µM) and shows competitive inhibition (Ki=118 µM)[1].

PTP4A1 Human Pre-designed siRNA Set A contains three designed siRNAs for PTP4A1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTP4A2 Human Pre-designed siRNA Set A contains three designed siRNAs for PTP4A2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTP4A3 Human Pre-designed siRNA Set A contains three designed siRNAs for PTP4A3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTPA Human Pre-designed siRNA Set A contains three designed siRNAs for PTPA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTPDC1 Human Pre-designed siRNA Set A contains three designed siRNAs for PTPDC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTPMT1 Human Pre-designed siRNA Set A contains three designed siRNAs for PTPMT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTPN1 Human Pre-designed siRNA Set A contains three designed siRNAs for PTPN1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTPN11 Human Pre-designed siRNA Set A contains three designed siRNAs for PTPN11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTPN12 Human Pre-designed siRNA Set A contains three designed siRNAs for PTPN12 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTPN13 Human Pre-designed siRNA Set A contains three designed siRNAs for PTPN13 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTPN14 Human Pre-designed siRNA Set A contains three designed siRNAs for PTPN14 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTPN18 Human Pre-designed siRNA Set A contains three designed siRNAs for PTPN18 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTPN2 Human Pre-designed siRNA Set A contains three designed siRNAs for PTPN2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTPN2/1-IN-3 (compound 4) is a modified, orally active PTPN2/N1 inhibitor based on ABBV-CLS-484 (HY-145923). PTPN2/1-IN-3 has anti-tumor effects, inhibiting PTPN2 with an IC50 of 9.3 nM and having an oral bioavailability of 93% in mice.[4][1].

PTPN20 Human Pre-designed siRNA Set A contains three designed siRNAs for PTPN20 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTPN21 Human Pre-designed siRNA Set A contains three designed siRNAs for PTPN21 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTPN22 Human Pre-designed siRNA Set A contains three designed siRNAs for PTPN22 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTPN23 Human Pre-designed siRNA Set A contains three designed siRNAs for PTPN23 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTPN3 Human Pre-designed siRNA Set A contains three designed siRNAs for PTPN3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTPN4 Human Pre-designed siRNA Set A contains three designed siRNAs for PTPN4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTPN5 Human Pre-designed siRNA Set A contains three designed siRNAs for PTPN5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTPN6 Human Pre-designed siRNA Set A contains three designed siRNAs for PTPN6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTPN7 Human Pre-designed siRNA Set A contains three designed siRNAs for PTPN7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTPN9 Human Pre-designed siRNA Set A contains three designed siRNAs for PTPN9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTPRA Human Pre-designed siRNA Set A contains three designed siRNAs for PTPRA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTPRB Human Pre-designed siRNA Set A contains three designed siRNAs for PTPRB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTPRC Human Pre-designed siRNA Set A contains three designed siRNAs for PTPRC gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTPRCAP Human Pre-designed siRNA Set A contains three designed siRNAs for PTPRCAP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTPRD Human Pre-designed siRNA Set A contains three designed siRNAs for PTPRD gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTPRE Human Pre-designed siRNA Set A contains three designed siRNAs for PTPRE gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTPRF Human Pre-designed siRNA Set A contains three designed siRNAs for PTPRF gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTPRG Human Pre-designed siRNA Set A contains three designed siRNAs for PTPRG gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTPRH Human Pre-designed siRNA Set A contains three designed siRNAs for PTPRH gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTPRJ Human Pre-designed siRNA Set A contains three designed siRNAs for PTPRJ gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTPRM Human Pre-designed siRNA Set A contains three designed siRNAs for PTPRM gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTPRN Human Pre-designed siRNA Set A contains three designed siRNAs for PTPRN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTPRN2 Human Pre-designed siRNA Set A contains three designed siRNAs for PTPRN2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTPRO Human Pre-designed siRNA Set A contains three designed siRNAs for PTPRO gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTPRQ Human Pre-designed siRNA Set A contains three designed siRNAs for PTPRQ gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.